STAGE OF DEVELOPMENT | |||||
---|---|---|---|---|---|
Program | Approach | Indication | Discovery | Lead Optimization | IND Enabling |
PLA-GBM™ (Internal) | Platelet-mediated delivery of siRNA/miRNA | Glioblastoma | ![]() | 2023 | |
PLA-ONCO™ (Out-Licensing)* or (For Partnering)* | Platelet-mediated delivery of siRNA | Solid Tumors | ![]() | 2024 |
CURRENT PIPELINE
(*) Plasfer is actively looking for partners to move this program forward